Tags

Type your tag names separated by a space and hit enter

First clinical cases of OXA-48-producing carbapenem-resistant Klebsiella pneumoniae in the United States: the "menace" arrives in the new world.
J Clin Microbiol 2013; 51(2):680-3JC

Abstract

OXA-48 has emerged as a major carbapenemase associated with the Enterobacteriaceae in Europe, North Africa, and Asia. We report the first two clinical cases of OXA-48-type carbapenemase-producing Enterobacteriaceae in the United States from patients recently hospitalized in Saudi Arabia and India. Each is more carbapenem resistant than nearly all previously reported OXA-48-type-producing Enterobacteriaceae.

Authors+Show Affiliations

Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia, USA. ajm5b@virginia.eduNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Case Reports
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.

Language

eng

PubMed ID

23175248

Citation

Mathers, Amy J., et al. "First Clinical Cases of OXA-48-producing Carbapenem-resistant Klebsiella Pneumoniae in the United States: the "menace" Arrives in the New World." Journal of Clinical Microbiology, vol. 51, no. 2, 2013, pp. 680-3.
Mathers AJ, Hazen KC, Carroll J, et al. First clinical cases of OXA-48-producing carbapenem-resistant Klebsiella pneumoniae in the United States: the "menace" arrives in the new world. J Clin Microbiol. 2013;51(2):680-3.
Mathers, A. J., Hazen, K. C., Carroll, J., Yeh, A. J., Cox, H. L., Bonomo, R. A., & Sifri, C. D. (2013). First clinical cases of OXA-48-producing carbapenem-resistant Klebsiella pneumoniae in the United States: the "menace" arrives in the new world. Journal of Clinical Microbiology, 51(2), pp. 680-3. doi:10.1128/JCM.02580-12.
Mathers AJ, et al. First Clinical Cases of OXA-48-producing Carbapenem-resistant Klebsiella Pneumoniae in the United States: the "menace" Arrives in the New World. J Clin Microbiol. 2013;51(2):680-3. PubMed PMID: 23175248.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - First clinical cases of OXA-48-producing carbapenem-resistant Klebsiella pneumoniae in the United States: the "menace" arrives in the new world. AU - Mathers,Amy J, AU - Hazen,Kevin C, AU - Carroll,Joanne, AU - Yeh,Anthony J, AU - Cox,Heather L, AU - Bonomo,Robert A, AU - Sifri,Costi D, Y1 - 2012/11/21/ PY - 2012/11/24/entrez PY - 2012/11/24/pubmed PY - 2013/7/3/medline SP - 680 EP - 3 JF - Journal of clinical microbiology JO - J. Clin. Microbiol. VL - 51 IS - 2 N2 - OXA-48 has emerged as a major carbapenemase associated with the Enterobacteriaceae in Europe, North Africa, and Asia. We report the first two clinical cases of OXA-48-type carbapenemase-producing Enterobacteriaceae in the United States from patients recently hospitalized in Saudi Arabia and India. Each is more carbapenem resistant than nearly all previously reported OXA-48-type-producing Enterobacteriaceae. SN - 1098-660X UR - https://www.unboundmedicine.com/medline/citation/23175248/full_citation L2 - http://jcm.asm.org/cgi/pmidlookup?view=long&pmid=23175248 DB - PRIME DP - Unbound Medicine ER -